Roche S.p.A.
- C10 - Agentes modificadores de los lípidos
- BEZALIP prolonged-release tablet 400 mg
- J01 - Antibacterianos para uso sistémico
- ROCEFIN powder and solvent for solution for injection 1 g+10 ml
- ROCEFIN powder and solvent for solution for injection 1 g+3.5 ml
- ROCEFIN powder and solvent for solution for injection 250 mg+2 ml
- ROCEFIN powder for solution for infusion 2 g
- ROCEFIN powder for solution for injection 1 g
- J05 - Antivirales de uso sistémico
- VALCYTE film-coated tablet 450 mg
- VALCYTE powder for oral solution 50 mg/ml
- N04 - Antiparkinsonianos
- MADOPAR capsule, hard 100 mg+25 mg
- MADOPAR capsule, hard 200 mg+50 mg
- MADOPAR dispersible tablet 100 mg+25 mg
- MADOPAR prolonged-release capsule, hard 100 mg+25 mg
- MADOPAR tablet 200 mg+50 mg
- R05 - Preparados para la tos y el resfriado
- PULMOZYME nebuliser solution 2.5 mg/2.5 ml